AZN logo

AZN
AstraZeneca PLC

18,869
Mkt Cap
$316.42B
Volume
1.57M
52W High
$212.71
52W Low
$132.32
PE Ratio
30.94
AZN Fundamentals
Price
$204.03
Prev Close
$204.99
Open
$207.30
50D MA
$196.36
Beta
0.42
Avg. Volume
1.94M
EPS (Annual)
$6.60
P/B
6.50
Rev/Employee
$611,227.89
$313,656.50
Loading...
Loading...
News
all
press releases
AstraZeneca's (AZN) "Buy" Rating Reiterated at Jefferies Financial Group
false
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Black Diamond Stock: Weighing Catalysts vs. Concentration
BDTX hinges on silevertinib's mutation breadth and CNS activity, with 2026 data, cash runway, and partnership moves set to shape its high-risk, high-reward path.
Zacks·2d ago
News Placeholder
BDTX: What Silevertinib Data Say About EGFR NSCLC Upside
BDTX bets on silevertinib's broad EGFR mutation reach and CNS activity, but with no approved products, upcoming 2026 data and partnerships are pivotal.
Zacks·2d ago
News Placeholder
AZN vs. MRK: Which Oncology Stock Offers Better Investment Potential?
Though both dominate oncology, a stronger growth outlook and clearer targets may give AstraZeneca an edge over Merck.
Zacks·2d ago
News Placeholder
Erste Group Bank Comments on Astrazeneca FY2026 Earnings
Astrazeneca Plc (NYSE:AZN - Free Report) - Erste Group Bank boosted their FY2026 earnings per share (EPS) estimates for Astrazeneca in a report released on Thursday, April 2nd. Erste Group Bank analyst H. Engel now anticipates that the company will earn $10.44 per share for the year, up from their p...
MarketBeat·2d ago
News Placeholder
How Pfizer's Oncology Portfolio Is Shaping Up Before Q1 Results
Pfizer's oncology unit displays mixed Q1 trends as key drugs and biosimilars offset Ibrance declines ahead of earnings on May 5
Zacks·3d ago
News Placeholder
The Zacks Analyst Blog Highlights AstraZeneca, HSBC, Walt Disney, Oak Valley Bancorp and BV Financial
AstraZeneca (AZN) leads Zacks Research highlights with strong drug growth and pipeline momentum, while HSBC and Disney navigate costs and competition.
Zacks·3d ago
News Placeholder
Sivik Global Healthcare LLC Makes New Investment in Astrazeneca Plc $AZN
Sivik Global Healthcare LLC bought a new position in Astrazeneca Plc (NYSE:AZN - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the...
MarketBeat·3d ago
<
...
1
>

Latest AZN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.